1
|
Rostamitabar M, Abdelgawad AM, Jockenhoevel S, Ghazanfari S. Drug-Eluting Medical Textiles: From Fiber Production and Textile Fabrication to Drug Loading and Delivery. Macromol Biosci 2021; 21:e2100021. [PMID: 33951278 DOI: 10.1002/mabi.202100021] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 03/30/2021] [Indexed: 12/16/2022]
Abstract
Drug-eluting medical textiles have recently gained great attention to be used in different applications due to their cost effectiveness and unique physical and chemical properties. Using various fiber production and textile fabrication technologies, fibrous constructs with the required properties for the target drug delivery systems can be designed and fabricated. This review summarizes the current advances in the fabrication of drug-eluting medical textiles. Different fiber production methods such as melt-, wet-, and electro-spinning, and textile fabrication techniques such as knitting and weaving are explained. Moreover, various loading processes of bioactive agents to obtain drug-loaded fibrous structures with required physicochemical and morphological properties, drug delivery mechanisms, and drug release kinetics are discussed. Finally, the current applications of drug-eluting fibrous systems in wound care, tissue engineering, and transdermal drug delivery are highlighted.
Collapse
Affiliation(s)
- Matin Rostamitabar
- Aachen-Maastricht Institute for Biobased Materials (AMIBM), Faculty of Science and Engineering, Maastricht University, Geleen, 6167 RD, The Netherlands.,Department of Biohybrid and Medical Textiles (BioTex), AME-Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, 52074, Germany
| | - Abdelrahman M Abdelgawad
- Aachen-Maastricht Institute for Biobased Materials (AMIBM), Faculty of Science and Engineering, Maastricht University, Geleen, 6167 RD, The Netherlands
| | - Stefan Jockenhoevel
- Aachen-Maastricht Institute for Biobased Materials (AMIBM), Faculty of Science and Engineering, Maastricht University, Geleen, 6167 RD, The Netherlands.,Department of Biohybrid and Medical Textiles (BioTex), AME-Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, 52074, Germany
| | - Samaneh Ghazanfari
- Aachen-Maastricht Institute for Biobased Materials (AMIBM), Faculty of Science and Engineering, Maastricht University, Geleen, 6167 RD, The Netherlands.,Department of Biohybrid and Medical Textiles (BioTex), AME-Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, 52074, Germany
| |
Collapse
|
2
|
Wang S, Pi L, Wen H, Yu H, Yang X. Evaluation of novel magnetic targeting microspheres loading adriamycin based on carboxymethyl chitosan. J Drug Deliv Sci Technol 2020. [DOI: 10.1016/j.jddst.2019.101388] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
|
3
|
Cao J, Yang B, Wang Y, Wei C, Wang H, Li S. Polymer brush hexadecyltrimethylammonium bromide (CTAB) modified poly (propylene-g-styrene sulphonic acid) fiber (ZB-1): CTAB/ZB-1 as a promising strategy for improving the dissolution and physical stability of poorly water-soluble drugs. MATERIALS SCIENCE & ENGINEERING. C, MATERIALS FOR BIOLOGICAL APPLICATIONS 2017; 80:282-295. [PMID: 28866166 DOI: 10.1016/j.msec.2017.05.139] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/25/2017] [Revised: 05/23/2017] [Accepted: 05/28/2017] [Indexed: 01/17/2023]
Abstract
The feasibility of polymer brush as drug delivery vehicle was demonstrated with the goal of improving the dissolution and physical stability of poorly water-soluble drugs. Polymer brush CTAB/ZB-1 was synthesized by electrostatic interaction using a physical modification method with anionic poly (propylene-g-styrene sulphonic acid) fiber (ZB-1) as the substrate and cationic hexadecyltrimethylammonium bromide (CTAB) as the modifier. The polymer brush structure of CTAB/ZB-1 was validated by atomic force microscopy (AFM) and the channels of brush provided the drug loading sites. Flurbiprofen (FP), a BCS class II representative drug, was selected as the model poorly water-soluble drug to be loaded into this polymer brush. Then the drug loading and release were systematically investigated. Besides, the transformation from crystalline FP to amorphous state was observed by differential scanning calorimeter (DSC). In vitro dissolution in pure water and pH1.2 HCl media with/without 0.1% sodium dodecyl sulfate (SDS) was tested. Moreover, the optimal formulations (namely carrier/drug ratios) were determined. The results demonstrated prominent improvement of dissolution when FP was released from CTAB/ZB-1. After a long time storage, FP remained amorphous in CTAB/ZB-1 according to DSC determinations and performed an approximately equivalent dissolution compared with fresh samples, suggesting the advantage of CTAB/ZB-1 as carrier in enhancing the physical stability of drugs. The study introduced the versatile easily formulated polymer brush CTAB/ZB-1 and demonstrated the potential of polymer brush as an alternative approach for improving the dissolution and physical stability of poorly water-soluble drugs.
Collapse
Affiliation(s)
- Jinxu Cao
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, PR China
| | - Baixue Yang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, PR China
| | - Yumei Wang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, PR China
| | - Chen Wei
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, PR China
| | - Hongyu Wang
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, PR China
| | - Sanming Li
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, PR China.
| |
Collapse
|
4
|
Drug-Loadable Calcium Alginate Hydrogel System for Use in Oral Bone Tissue Repair. Int J Mol Sci 2017; 18:ijms18050989. [PMID: 28481253 PMCID: PMC5454902 DOI: 10.3390/ijms18050989] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2017] [Revised: 05/01/2017] [Accepted: 05/02/2017] [Indexed: 01/23/2023] Open
Abstract
This study developed a drug-loadable hydrogel system with high plasticity and favorable biological properties to enhance oral bone tissue regeneration. Hydrogels of different calcium alginate concentrations were prepared. Their swelling ratio, degradation time, and bovine serum albumin (BSA) release rate were measured. Human periodontal ligament cells (hPDLCs) and bone marrow stromal cells (BMSCs) were cultured with both calcium alginate hydrogels and polylactic acid (PLA), and then we examined the proliferation of cells. Inflammatory-related factor gene expressions of hPDLCs and osteogenesis-related gene expressions of BMSCs were observed. Materials were implanted into the subcutaneous tissue of rabbits to determine the biosecurity properties of the materials. The materials were also implanted in mandibular bone defects and then scanned using micro-CT. The calcium alginate hydrogels caused less inflammation than the PLA. The number of mineralized nodules and the expression of osteoblast-related genes were significantly higher in the hydrogel group compared with the control group. When the materials were implanted in subcutaneous tissue, materials showed favorable biocompatibility. The calcium alginate hydrogels had superior osteoinductive bone ability to the PLA. The drug-loadable calcium alginate hydrogel system is a potential bone defect reparation material for clinical dental application.
Collapse
|
5
|
Yuan J, Liu T, Li H, Shi T, Xu J, Liu H, Wang Z, Wang Q, Xu L, Wang Y, Li S. Oral sustained-release suspension based on a novel taste-masked and mucoadhesive carrier–ion-exchange fiber. Int J Pharm 2014; 472:74-81. [DOI: 10.1016/j.ijpharm.2014.05.048] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2014] [Revised: 05/23/2014] [Accepted: 05/28/2014] [Indexed: 10/25/2022]
|